88064933 - HEIDELBERG PHARMA

Information

  • Trademark
  • 88064933
  • Serial Number
    88064933
  • Registration Number
    6021542
  • Filing Date
    August 03, 2018
    6 years ago
  • Registration Date
    March 31, 2020
    4 years ago
  • Transaction Date
    January 06, 2021
    3 years ago
  • Status Date
    March 31, 2020
    4 years ago
  • Published for Opposition Date
    January 14, 2020
    4 years ago
  • Location Date
    March 31, 2020
    4 years ago
  • Status Code
    700
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    KEATING, MICHAEL P
  • Attorney Docket Number
    13318.1006US
    Attorney Name
    Scott D. Marty, JD, PhD
    Law Office Assigned Location Code
    L10
  • Owners
Mark Drawing Code
3000
Mark Identification
HEIDELBERG PHARMA
Case File Statements
  • CC0000: The color(s) blue and light blue is/are claimed as a feature of the mark.
  • D10000: "PHARMA"
  • DM0000: The mark consists of a blue circle within another light blue partial circular design, to the right of which appears the stylized word "Heidelberg" in blue letters. Appearing within the partial circular design, and under the word "Heidelberg" is the stylized word "PHARMA" in blue upper-case letters.
  • GS0011: Biochemicals, namely, monoclonal antibodies for in vitro scientific or research use
  • GS0051: Pharmaceutical preparations for the treatment of immuno oncological disorders, namely, cancer; pharmaceuticals for cancer therapy; chemico-pharmaceutical preparations for cancer therapies; pharmaceutical preparations and substances for use in the treatment of cancer; chemical preparations for pharmaceutical purposes, namely, for the treatment of cancer; pharmaceutical preparations for human use, namely, for the treatment of cancer; pharmaceutical preparations for use in oncology; pharmaceutical preparations for use in chemotherapy; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations and substances for the treatment of cancer; pharmaceutical preparations and substances for use in oncology; diagnostic preparations for medical purposes; diagnostic agents for pharmaceutical use; diagnostic agents for medical use; clinical diagnostic reagents; diagnostic chemical reagents for medical use; anti-cancer drugs; compounds for treating cancer; anti-cancer preparations; anti-cancer preparations of chemical origin; biopharmaceuticals for the treatment of cancer; pharmaceutical preparations and substances for the prevention of cancer; chemotherapeutics; diagnostic kits consisting primarily of monoclonal antibodies for use in disease testing
  • GS0421: Pharmaceutical research services; medical and pharmacological research services; pharmaceutical products development; development of pharmaceutical preparations and medicines; consultancy relating to pharmaceutical research and development; scientific research; medical research; biomedical research services; research relating to biotechnology; research on the subject of pharmaceuticals; consultancy relating to research in the field of pharmacogenetics; research and development in the pharmaceutical and biotechnology fields; research and development in the field of diagnostic preparations; research and development in the field of biotechnology; research and development for the pharmaceutical industry; research and development services in the field of antibody technology; research and development services in the field of antibodies; laboratory services relating to the production of monoclonal antibodies
  • GS0441: Pharmaceutical advice; pharmaceutical services, namely, providing pharmaceutical advice and consultation and dispensing drugs to patients with cancer; consultancy and medical information services relating to pharmaceutical products
  • TF0000: As to "HEIDELBERG PHARMA"
Case File Event Statements
  • 1/5/2021 - 3 years ago
    31 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN
  • 1/5/2021 - 3 years ago
    30 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 1/5/2021 - 3 years ago
    29 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 1/5/2021 - 3 years ago
    28 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 1/5/2021 - 3 years ago
    27 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR
  • 3/31/2020 - 4 years ago
    26 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 1/14/2020 - 4 years ago
    25 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 1/14/2020 - 4 years ago
    24 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 12/25/2019 - 4 years ago
    23 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 12/12/2019 - 4 years ago
    22 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 12/12/2019 - 4 years ago
    21 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 12/12/2019 - 4 years ago
    20 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 12/12/2019 - 4 years ago
    19 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 12/12/2019 - 4 years ago
    18 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 11/18/2019 - 4 years ago
    17 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 11/18/2019 - 4 years ago
    16 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 11/16/2019 - 4 years ago
    15 - ASSIGNED TO LIE Type: ALIE
  • 11/11/2019 - 4 years ago
    14 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 5/9/2019 - 5 years ago
    13 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 5/9/2019 - 5 years ago
    12 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 5/9/2019 - 5 years ago
    11 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 4/26/2019 - 5 years ago
    10 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 4/26/2019 - 5 years ago
    9 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 4/26/2019 - 5 years ago
    8 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 11/26/2018 - 5 years ago
    7 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 11/26/2018 - 5 years ago
    6 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 11/26/2018 - 5 years ago
    5 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 11/21/2018 - 5 years ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 8/10/2018 - 6 years ago
    3 - NOTICE OF DESIGN SEARCH CODE E-MAILED Type: MDSC
  • 8/9/2018 - 6 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS
  • 8/7/2018 - 6 years ago
    1 - NEW APPLICATION ENTERED IN TRAM Type: NWAP